SEMAPA SOCIEDADE DE INVESTIM financials
SEMAPA SOCIEDADE DE INVESTIM
Country: PT Reporting currency: EUR Latest annual report: 2022-12-31
LEI:
549300HNGOW85KIOH584 ISIN: PTSEM0AM0004 Financial statements
(EUR, as reported — unscaled; 115 line items across 2 annual periods)
| Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | €3.12B | €2.13B |
| Other income | €165.3M | €96.9M |
| Employee benefits expense | €281.8M | €248.3M |
| Operating profit (EBIT) | €641.8M | €310.1M |
| Finance costs | €101.4M | €56.5M |
| Profit before tax | €557.6M | €267.9M |
| Income tax expense | €135.6M | €18.0M |
| Profit for the year | €422.1M | €250.0M |
| — attributable to owners | €307.1M | €198.1M |
| — attributable to NCI | €115.0M | €51.8M |
| Total comprehensive income | €504.9M | €222.2M |
| Per share | ||
| Basic EPS | €3.85 | €2.48 |
| Diluted EPS | €3.85 | €2.48 |
| Free cash flow / share | €5.02 | €3.58 |
| Cash flow statement | ||
| Cash generated from operations | €821.0M | €485.6M |
| Net cash from operating activities | €730.9M | €486.3M |
| Net cash from investing activities | -€200.7M | -€141.2M |
| Purchase of PP&E (capex) | €179.5M | €125.7M |
| Purchase of intangibles | €3.3M | €17.4M |
| Net cash from financing activities | -€331.8M | -€408.3M |
| Dividends paid | €216.3M | €86.2M |
| Proceeds from borrowings | €1.26B | €1.93B |
| Repayments of borrowings | €1.28B | €2.19B |
| Lease liability payments | €23.8M | €19.9M |
| Net change in cash | €198.4M | -€63.2M |
| Balance sheet | ||
| Total assets | €4.56B | €3.87B |
| Non-current assets | €2.90B | €2.78B |
| Property, plant & equipment | €1.68B | €1.73B |
| Right-of-use assets | €101.2M | €97.4M |
| Intangible assets & goodwill | €338.8M | €333.8M |
| Current assets | €1.65B | €1.09B |
| Inventories | €393.5M | €259.4M |
| Trade & other receivables | €642.0M | €432.1M |
| Cash & equivalents | €593.4M | €382.3M |
| Total equity | €1.63B | €1.35B |
| — attributable to owners | €1.32B | €1.09B |
| Non-controlling interests | €310.2M | €253.1M |
| Non-current liabilities | €1.47B | €1.53B |
| Long-term borrowings | €1.05B | €1.12B |
| Lease liabilities (non-current) | €84.9M | €81.4M |
| Current liabilities | €1.45B | €996.4M |
| Short-term borrowings | €336.0M | €278.2M |
| Lease liabilities (current) | €16.3M | €15.3M |
| Trade & other payables | €960.9M | €647.4M |
| Deferred tax liabilities | €237.3M | €231.4M |
| Derived metrics | ||
| Free cash flow | €551.5M | €360.6M |
| Operating margin | 20.6% | 14.5% |
| Net margin | 13.5% | 11.7% |
| Return on equity | 25.8% | 18.6% |
| Cash conversion ratio | 1.73× | 1.95× |
| Capex coverage | 4.07× | 3.87× |
| Other reported items | ||
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €443.0K | €1.2M |
| Cash and Cash Equivalents In Subsidiary Or Businesses Acquired Or Disposed2013 | €0 | €155.1K |
| Changes In Inventories of Finished Goods and Work In Progress | -€90.8M | -€5.1M |
| Changes In Other Provisions | -€3.9M | -€4.7M |
| Comprehensive Income Attributable To Noncontrolling Interests | €132.7M | €38.3M |
| Comprehensive Income Attributable To Owners of Parent | €372.2M | €183.9M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €1.65B | €1.08B |
| Current Tax Assets Current | €23.7M | €8.3M |
| Current Tax Liabilities Current | €141.3M | €55.6M |
| Deferred Tax Assets | €85.9M | €90.3M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €248.4M | €193.9M |
| Dividends Received From Investments Accounted For Using Equity Method Classified As Investing Activities | €2.0M | €1.1M |
| Dividends Recognised As Distributions To Noncontrolling Interests | €75.4M | €45.2M |
| Dividends Recognised As Distributions To Owners of Parent | €140.9M | €40.9M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €13.5M | -€6.9K |
| Equity and Liabilities | €4.56B | €3.87B |
| Finance Income | €8.7M | €5.0M |
| Gains Losses On Fair Value Adjustment Biological Assets | -€24.8M | -€1.3M |
| Gains Losses On Net Monetary Position | €979.1K | €7.2M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | €16.6M | €626.4K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -€593.5K | €317.7K |
| Income Taxes Paid Refund Classified As Operating Activities | €47.7M | €23.3M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | — | €344.5K |
| Increase Decrease Through Transactions With Owners | -€216.7M | -€84.7M |
| Increase Decrease Through Transfers and Other Changes Equity | €1 | -€42.4K |
| Inflows of Cash From Investing Activities | €8.8M | €19.4M |
| Intangible Assets Other Than Goodwill | €455.1M | €345.1M |
| Interest Paid Classified As Financing Activities | €58.5M | €38.8M |
| Interest Received Classified As Investing Activities | €853.0K | €5.9M |
| Investment Accounted For Using Equity Method | €38.4M | €4.1M |
| Investment Property | €366.4K | €368.8K |
| Issued Capital | €81.3M | €81.3M |
| Liabilities | €2.92B | €2.53B |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €1.0M | €4.2M |
| Noncurrent Biological Assets | €122.5M | €147.3M |
| Noncurrent Payables | €37.7M | €37.0M |
| Noncurrent Provisions For Employee Benefits | €5.6M | €6.9M |
| Noncurrent Receivables | €28.9M | €12.1M |
| Other Comprehensive Income | €82.8M | -€27.8M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | €60.6M | €2.3M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | €37.7M | -€29.5M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €1.0M | €2.3M |
| Other Expense By Nature | €155.1M | €79.6M |
| Other Individually Immaterial Components of Other Comprehensive Income Net of Tax | -€555.4K | -€1.9M |
| Other Inflows Outflows of Cash Classified As Operating Activities | -€42.3M | €24.0M |
| Other Longterm Provisions | €53.3M | €52.5M |
| Other Noncurrent Financial Assets | €48.7M | €21.2M |
| Outflows of Cash From Investing Activities | €209.6M | €160.7M |
| Payments To and On Behalf of Employees | €194.6M | €170.2M |
| Payments To Suppliers For Goods and Services | €2.22B | €1.56B |
| Proceeds From Other Longterm Assets Classified As Investing Activities | €32.0K | — |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €1.8M | €6.6M |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €4.2M | €5.8M |
| Purchase of Financial Instruments Classified As Investing Activities | €26.8M | €17.7M |
| Receipts From Sales of Goods and Rendering of Services | €3.23B | €2.21B |
| Reserve of Cash Flow Hedges | €29.9M | -€2.3M |
| Reserve of Exchange Differences On Translation | -€202.2M | -€234.8M |
| Retained Earnings Excluding Profit Loss For Reporting Period | €990.8K | €832.8K |
| Retained Earnings Profit Loss For Reporting Period | €307.1M | €198.1M |
| Services Expense | €817.7M | €608.0M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €7.5M | €2.1M |
| Statutory Reserve | €16.7M | €16.7M |
| Treasury Shares | €15.9M | €15.9M |
Methodology
Every line item above is a fact tagged in SEMAPA SOCIEDADE DE INVESTIM's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.